Clinical Edge Journal Scan

Topical POLG nanoemulsion improves dryness and itchiness in atopic dermatitis


 

Key clinical point: Daily continuous use of 10% phytosteryl/octyldodecyl lauroyl glutamate (POLG) nanoemulsion improved several dry skin symptoms and itchiness in patients with atopic dermatitis (AD).

Major finding: Significant improvement was observed with POLG nanoemulsion in itchiness as early as at 3 weeks (P < .05) and dryness at 6 weeks (P < .01). By 6 weeks, scaliness and smoothness of the skin were also significantly improved (P < .01).

Study details: Findings are from a clinical study including patients with AD who received 10% POLG nanoemulsion for 6 weeks.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Takada M et al. A nano-emulsion containing ceramide-like lipo-amino acid cholesteryl derivatives improves skin symptoms in patients with atopic dermatitis by ameliorating the water-holding function. Int J Mol Sci. 2022;23(21):13362 (Nov 1). Doi: 10.3390/ijms232113362

Recommended Reading

Breaking the itch-scratch cycle with mindfulness
MDedge Dermatology
Serum dupilumab levels do not predict clinical response
MDedge Dermatology
Atopic dermatitis: Dupilumab serum levels not associated with treatment response or adverse effects
MDedge Dermatology
Exposure to wildfire air pollution increases atopic dermatitis risk in older adults
MDedge Dermatology
Moderate-to-severe atopic dermatitis: No increased infection risk with long-term dupilumab use
MDedge Dermatology
Long-term efficacy of baricitinib in moderate-to-severe atopic dermatitis
MDedge Dermatology
Long-term efficacy of baricitinib in moderate-to-severe atopic dermatitis
MDedge Dermatology
Atopic dermatitis patients with good clinical response or conjunctivitis may opt for longer dupilumab dosing interval
MDedge Dermatology
Topical prebiotics and postbiotics effective and well tolerated in mild-to-moderate atopic dermatitis
MDedge Dermatology
Emollient use in the first year of life does not protect against atopic dermatitis in the long term
MDedge Dermatology